Female Stress Urinary Incontinence
Treatment depends on symptom burden, urethral support and function, prior surgery, emptying, health and patient goals. Discuss observation, pelvic-floor muscle training, continence devices and procedural options. A patient need not progress through every procedure in this database before choosing surgery.[1]
Assessment and Treatment Selection
Before an operation, document stress leakage, pelvic examination, urinalysis and postvoid residual. Urethral mobility and sphincter function are separate assessments. Urodynamics may be omitted in an uncomplicated index patient with clearly demonstrated SUI; uncertainty, voiding dysfunction, prior surgery or other non-index features warrant additional evaluation. There is no universal residual-volume threshold that alone defines every complicated case.[1][2]
| Clinical situation | Options to discuss | Important distinction |
|---|---|---|
| Primary SUI or stress-predominant mixed incontinence | PFMT, continence pessary; MUS, autologous PVS, Burch or bulking when a procedure is chosen | Expected stress-leakage benefit and urgency outcomes differ. Treatment is a shared choice. |
| Mesh avoidance | Autologous PVS, Burch, or bulking | PVS adds harvest morbidity; Burch requires abdominal access; bulking may need repeat treatment. Mesh avoidance does not remove all complications. |
| Lower procedural burden preferred | Continence devices or urethral bulking | Anesthesia and repeat-treatment needs depend on the procedure and setting; age alone does not prescribe one treatment. |
| Fixed, immobile urethra | PVS, retropubic MUS, bulking or an adjustable retropubic sling | AUA/SUFU's discussion favors PVS for a nonmobile urethra. This is not synonymous with every low leak-point-pressure result. |
| Concurrent urethral diverticulectomy, urethrovaginal fistula repair or urethral mesh excision | Individualize concurrent versus staged continence surgery; autologous fascia if an accompanying sling is appropriate | Avoid a synthetic MUS during these repairs. Remote healed surgery is a different situation. |
| Prolapse with symptomatic, occult or absent SUI | Concomitant versus staged continence treatment | Separate these populations and the prolapse route. Evidence for one procedure does not mandate a prophylactic sling or Burch for everyone. |
| Recurrent SUI after surgery | Reassess stress leakage, urgency, obstruction, emptying, tissue and prior implants before choosing further treatment | Repeating a sling or selecting a female AUS is not an automatic next step. |
| Severe refractory outlet dysfunction | Specialist discussion of reconstructive options, selected obstructing PVS or bladder-neck closure with drainage; selected female AUS after failed surgery | Bladder storage safety, catheterization ability, device revisions and irreversible consequences require explicit planning. |
| Genitourinary syndrome of menopause | Treat coexisting GSM, including vaginal estrogen when appropriate | This addresses associated genitourinary symptoms; it does not replace evaluation and treatment of demonstrable SUI. |
The framework reflects AUA/SUFU and NICE guidance. Recommendations differ by jurisdiction: AUA/SUFU permits retropubic, transobturator and single-incision MUS in index patients, whereas NICE places additional restrictions on transobturator and single-incision approaches.[1][2]
Comparing Operations
Use the dedicated retropubic MUS, transobturator MUS, single-incision sling, PVS, Burch and bulking pages for their trial populations, endpoints and harms. Discuss bladder injury, emptying, pain, mesh or suture complications, donor wounds, recovery and retreatment in the context of the actual operation.[1][2]
Cure, improvement and satisfaction are different outcomes. A nonsignificant comparison does not establish equivalence, and a network ranking score is not an individual patient's cure probability. Traditional-sling reviews also contain historical materials and techniques; their pooled results cannot be treated as one modern autologous operation.[3]
Treatment Database
| Treatment | Category | Best for / indication |
|---|---|---|
| Pelvic Floor Physical Therapy (PFMT ± Biofeedback) | Conservative | Conservative treatment for SUI; supervised training and shared treatment goals. |
| Behavioral & Lifestyle Modifications | Conservative | Universal adjunct — fluid / caffeine / constipation / smoking modifications. |
| Weight Loss | Conservative | Weight management when appropriate; symptom benefit varies. |
| Continence Pessary | Conservative | Bridge to surgery, pregnancy plans, or non-surgical preference. |
| Poise Impressa | Conservative | Situational / activity-related SUI; OTC self-fitted intravaginal continence device. |
| Absorbent Products & Pad Test | Containment / Diagnostic | Containment during workup or treatment; pad-weight test for severity and outcome tracking. |
| Barrier Creams & IAD Prevention | Containment / Diagnostic | Chronic pad / catheter users; prevention and treatment of incontinence-associated dermatitis. |
| Pelvic Floor Electrical Stimulation | Conservative | Patients who cannot voluntarily contract the pelvic floor. |
| Duloxetine | Pharmacological | Selected medical treatment; licensing, adverse effects and withdrawal differ by jurisdiction. |
| Topical Vaginal Estrogen | Pharmacological | Postmenopausal SUI with GSM-driven irritative overlay. |
| Urethral Bulking Agents | Minimally Invasive | Lower procedural burden or preference against other surgery; discuss durability and repeat injections. |
| Vaginal Laser Therapy (CO₂ / Er:YAG) | Minimally Invasive | Investigational; FDA 2018 warning — research protocols only. |
| Retropubic Mid-Urethral Sling (TVT) | Surgical | Established SUI operation; counsel about retropubic passage and mesh risks. |
| Transobturator Mid-Urethral Sling (TOT / TVT-O) | Surgical | Hypermobility SUI when retropubic-space access is suboptimal; lower bladder-injury risk. |
| Single-Incision Mini-Sling | Surgical | Hypermobility SUI; local-anesthesia placement; smaller footprint. |
| Autologous Fascial Pubovaginal Sling | Surgical | Primary or selected recurrent SUI; mesh avoidance or appropriate concurrent urethral repair. |
| Burch Colposuspension | Surgical | Mesh-free suture option when anatomy, abdominal access and patient goals are suitable. |
| Artificial Urinary Sphincter (AUS) | Salvage | Selected refractory SUI after failed surgery; specialist assessment and device counseling. |
| Obstructing Autologous PVS / Bladder-Neck Closure | Salvage | Selected severe outlet dysfunction; individualized safe storage and long-term urinary drainage. |
| Urinary Diversion | Salvage | Last resort — intractable incontinence with non-functional outlet. |
References
1. AUA/SUFU. Surgical Treatment of Female Stress Urinary Incontinence. 2023 amendment. Official guideline.
2. NICE. Urinary incontinence and pelvic organ prolapse in women: management. NG123. Recommendations.
3. Saraswat L, Rehman H, Omar MI, Cody JD, Aluko P, Glazener CMA. Traditional suburethral sling operations for urinary incontinence in women. Cochrane Database Syst Rev. 2020;1:CD001754. doi:10.1002/14651858.CD001754.pub5.